about
Characterization of mammalian Ecm29, a 26 S proteasome-associated protein that localizes to the nucleus and membrane vesiclesCDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegenerationQuantitative methods to analyze subnuclear protein organization in cell populations with varying degrees of protein expression.Structural transformation of the tandem ubiquitin-interacting motifs in ataxin-3 and their cooperative interactions with ubiquitin chains.The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells.A two-step path to inclusion formation of huntingtin peptides revealed by number and brightness analysis.Huntingtin fragments and SOD1 mutants form soluble oligomers in the cellComprehensive functional annotation of seventy-one breast cancer risk Loci.Novel therapeutic targets for Huntington's disease.Mitochondrial dysfunction precedes neurodegeneration in mahogunin (Mgrn1) mutant miceThe genetics of neurodegenerative diseases.Asparaginyl endopeptidase cleaves TDP-43 in brainExpression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease.Pharmacological protein targets in polyglutamine diseases: mutant polypeptides and their interactors.A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3.Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate.Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.Protein composition of the intranuclear inclusions of FXTAS.Ataxin-3 is subject to autolytic cleavage.
P2860
Q24307896-F75D7ECD-80A8-465A-A22F-BC2C06792CDCQ24337541-414B97A7-348F-461A-98AB-E4C461563614Q30436907-94897BD5-8C23-4DEE-ADAC-5F09EBA234D9Q33719392-352E1C99-19A1-434D-A900-98986D3A17D6Q33739563-13CCA8EB-6E9C-488B-B84B-94C9B75F92B4Q33908362-1ECF6A42-6C3F-4FE8-9B2A-C57B5B432967Q34328850-DCF67452-73AD-437C-8F4A-CD3098E8C324Q34744860-17A2A7E5-C078-4822-8138-EB92DB5C7660Q36219680-1FD25151-1DAC-4A9C-B93C-DFDF55978BB2Q36248089-BC828956-507E-492E-BCA2-DE0BA4D748DEQ36521941-7607FF80-5160-4E37-BAAF-BFADF701CE7EQ37208989-1315C079-4E20-4E12-ACF5-F51B313FEBBFQ37338808-BFC02194-E671-46CB-A4A2-BB464A70A016Q38107677-7440F944-44E2-4E8F-AD45-0630A758A025Q38882170-5C7B83E1-DCDF-45E9-9D6D-E03241211B27Q41626376-247DBB2C-C013-44C1-87B8-7C10FFF3EDE8Q42818202-5F65DD64-CE07-47F4-B371-DBE9CF451034Q44053371-0747EECA-36B7-4597-8748-24F35BE25B03Q51139567-40CF6238-C6FF-4AC5-BE7D-985A9F1BB21D
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Role of proteolysis in polyglutamine disorders.
@ast
Role of proteolysis in polyglutamine disorders.
@en
type
label
Role of proteolysis in polyglutamine disorders.
@ast
Role of proteolysis in polyglutamine disorders.
@en
prefLabel
Role of proteolysis in polyglutamine disorders.
@ast
Role of proteolysis in polyglutamine disorders.
@en
P356
P1476
Role of proteolysis in polyglutamine disorders.
@en
P2093
P2860
P304
P356
10.1002/JNR.10746
P577
2003-11-01T00:00:00Z